These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8573174)

  • 1. Angiotensin converting enzyme inhibitor normalizes vascular natriuretic peptide type A receptor gene expression via bradykinin-dependent mechanism in hypertensive rats.
    Yoshimoto T; Naruse K; Shionoya K; Tanaka M; Seki T; Hagiwara H; Hirose S; Kuen LS; Demura H; Naruse M; Muraki T
    Biochem Biophys Res Commun; 1996 Jan; 218(1):50-3. PubMed ID: 8573174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.
    Yoshimoto T; Naruse M; Naruse K; Shionoya K; Tanaka M; Tanabe A; Hagiwara H; Hirose S; Muraki T; Demura H
    Endocrinology; 1996 Mar; 137(3):1102-7. PubMed ID: 8603580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitor but not calcium blocker down-regulates gene expression of vascular natriuretic peptide receptor in hypertensive rats.
    Yoshimoto T; Naruse M; Tanabe A; Naruse K; Takagi K; Muraki T; Itakura M; Hagiwara H; Hirose S; Demura H
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1595-600. PubMed ID: 7811241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T; Inada Y; Ojima M; Sanada T; Shibouta Y; Nishikawa K
    Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
    Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
    Chen S; Kashiwabara H; Kosegawa I; Ishii J; Katayama S
    Clin Exp Hypertens; 1996 Jul; 18(5):625-36. PubMed ID: 8781750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
    Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.
    Nishikimi T; Yamagishi H; Takeuchi K; Takeda T
    Cardiovasc Res; 1995 Jun; 29(6):856-61. PubMed ID: 7656290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition.
    Bouaziz H; Joulin Y; Safar M; Benetos A
    Br J Pharmacol; 1994 Nov; 113(3):717-22. PubMed ID: 7858859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S; Iwao H
    J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of the type-1 angiotensin II receptor in rat adrenal gland.
    Wakamiya R; Kohara K; Hiwada K
    Blood Press Suppl; 1994; 5():109-12. PubMed ID: 7889191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
    J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
    Yu H; Rakugi H; Higaki J; Morishita R; Mikami H; Ogihara T
    J Hypertens; 1993 Dec; 11(12):1347-55. PubMed ID: 8133017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
    Yayama K; Sugiyama K; Miyagi R; Okamoto H
    Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.